RECENT PUBLICATIONS ABOUT OUR RESEARCH

Fung, K., Straub, L., Bateman, B. T., Hernandez-Diaz, S., Brill, G., Zhu, Y., Cohen, L. S., Gray, K. J., & Huybrechts, K. F. (2026). Z-Drug Use in the First Trimester of Pregnancy and Risk of Congenital Malformations. JAMA psychiatry, 83(2), 162–171. https://doi.org/10.1001/jamapsychiatry.2025.3874 

Goodman, D. W., Mago, R., Citrome, L., Swartz, H. A., McIntyre, R. S., Freeman, M. P., Clayton, A. H., Kasper, S., Vieta, E., Williams, A. R., Frye, M. A., Gitlin, M. J., Cohen, L. J., Correll, C. U., Gorwood, P., Iosifescu, D. V., Jha, M. K., Kupka, R., Macaluso, M., Malhi, G. S., … Goldberg, J. F. (2026). The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD?. European neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology, 111, 112863. Advance online publication. https://doi.org/10.1016/j.euroneuro.2026.112863 

Scalise, A. L., Yoon, H. E., Barest, P. E., Gaw, M. L., Freeman, M. P., Cohen, L. S., & Vanderkruik, R. C. (2026). Enhancing support for postpartum psychosis through a socio-ecological lens: A qualitative analysis. Journal of health psychology, 13591053261460698. Advance online publication. https://doi.org/10.1177/13591053261460698 

Viguera, A. C., Freeman, M. P., Slaby, E. K., Manuelian, A. M., Gaccione, P., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2026). Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications. Bipolar disorders, 28(5), e70138. https://doi.org/10.1111/bdi.70138 

Freeman, M. P., Viguera, A. C., Manuelian, A. M., Grassi, E. J., Murphy, B. B., & Cohen, L. S. (2026). Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications. Journal of clinical psychopharmacology, 10.1097/JCP.0000000000002221. Advance online publication. https://doi.org/10.1097/JCP.0000000000002221 

Snyder, H., Streem, D., Anand, A., & Viguera, A. C. (2026). When risks outweigh benefits: A review of the guideline on benzodiazepine tapering. Cleveland Clinic journal of medicine, 93(6), 347–352. https://doi.org/10.3949/ccjm.93a.25102 

Goldberg, J. F., Swartz, H. A., McIntyre, R. S., Mago, R., Malhi, G. S., Jha, M. K., Berk, M., Kasper, S., Freeman, M. P., Gitlin, M. J., Sajatovic, M., Ostacher, M. J., Citrome, L., Iosifescu, D. V., Perlis, R. H., Furukawa, T. A., Vieta, E., Thase, M. E., Young, A. H., Tohen, M., … Clayton, A. H. (2026). The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus. The British journal of psychiatry : the journal of mental science, 1–9. Advance online publication. https://doi.org/10.1192/bjp.2026.10580 

Goldberg, J. F., McIntyre, R. S., Swartz, H. A., Freeman, M. P., Mago, R., Citrome, L., Rosenblat, J. D., Thase, M. E., Tohen, M., Vieta, E., Malhi, G. S., Sajatovic, M., Shelton, R. C., Macaluso, M., Berk, M., Perlis, R. H., Ostacher, M. J., Khan, A., Iosifescu, D. V., Sanacora, G., … American Society of Clinical Psychopharmacology Task Force on the Deprescribing of Psychotropic Medications (2026). Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force. JAMA network open, 9(2), e260043. https://doi.org/10.1001/jamanetworkopen.2026.0043 

Vanderkruik, R., Falkenstein, M. J., & Abramowitz, J. S. (2025). Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort. The Journal of clinical psychiatry, 87(1), 25l16145. https://doi.org/10.4088/JCP.25l16145 

Vanderkruik, R., Frisch, C. M., Woodworth, E. C., Scharner, S., Bartels, S. J., Freeman, M. P., Cohen, L. S., & Stice, E. (2025). The pregnant body project pilot RCT protocol: Preventing disordered eating behaviors in high-risk pregnant individuals. Contemporary clinical trials, 156, 108039. https://doi.org/10.1016/j.cct.2025.108039 

Cohen, L. S., Arakelian, M., Church, T. R., Dunk, M. M., Gaw, M. L., Yoon, H. E., Kobylski, L. A., Vanderkruik, R., & Freeman, M. P. (2025). The phenomenology of postpartum psychosis: preliminary findings from the Massachusetts General Hospital Postpartum Psychosis Project. Molecular psychiatry, 30(6), 2537–2544. https://doi.org/10.1038/s41380-024-02856-3 

Vanderkruik, R., Freeman, M. P., Gaw, M., Reuman, A. R. L., Verghese, M., Louis, C. C., Jellinek, M., Bartels, S., & Cohen, L. S. (2025). A mixed-methods study protocol: Perinatal depression screening systems and outcomes in obstetrics clinics. PloS one, 20(3), e0319181. https://doi.org/10.1371/journal.pone.0319181 

Vanderkruik, R., Woodworth, E. C., Frisch, C. M., Nelson, S., Dunk, M. M., Freeman, M. P., Cohen, L. S., Stice, E., & Bartels, S. J. (2025). Application of implementation science frameworks to inform the adaptation process of an evidence-based eating disorder prevention program for high-risk perinatal individuals. Implementation research and practice, 6, 26334895251319811. https://doi.org/10.1177/26334895251319811 

Hamlett, G. E., Schrader, C., Ferguson, C., Kobylski, L. A., Picard, R., Locascio, J. J., McNally, R. J., Cohen, L. S., & Vanderkruik, R. (2025). Considering Comorbidities and Individual Differences in Testing a Gaming Behavioral Activation App for Perinatal Depression and Anxiety: Open Trial Pilot Intervention Study. JMIR formative research, 9, e59154. https://doi.org/10.2196/59154

Viguera A. C. (2024). Polypharmacy for perinatal mood and anxiety disorders. The lancet. Psychiatry, 11(8), 575–577. https://doi.org/10.1016/S2215-0366(24)00215-3 

Greenberg, J. L., Weingarden, H., Hoeppner, S. S., Berger-Gutierrez, R. M., Klare, D., Snorrason, I., Costilla-Reyes, O., Talbot, M., Daniel, K. E., Vanderkruik, R. C., Solar-Lezama, A., Harrison, O., & Wilhelm, S. (2024). Predicting response to a smartphone-based cognitive-behavioral therapy for body dysmorphic disorder. Journal of affective disorders, 355, 106–114. https://doi.org/10.1016/j.jad.2024.03.044 

Kobylski, L. A., Le, H. N., Freeman, M. P., Cohen, L. S., & Vanderkruik, R. (2024). Enhancing Postpartum Psychosis Care With Qualitative Research: Current Findings and Future Directions. The Journal of clinical psychiatry, 85(2), 24com15305. https://doi.org/10.4088/JCP.24com15305 

Vanderkruik, R., Kobylski, L. A., Dunk, M. M., Arakelian, M. H., Gaw, M. L., Dineen, H., Kanamori, M., Freeman, M. P., & Cohen, L. S. (2024). The lived experiences of individuals with postpartum psychosis: A qualitative analysis. Journal of affective disorders, 348, 367–377. https://doi.org/10.1016/j.jad.2023.12.069 

Kobylski, L. A., Arakelian, M. H., Freeman, M. P., Gaw, M. L., Cohen, L. S., & Vanderkruik, R. (2024). Barriers to care and treatment experiences among individuals with postpartum psychosis. Archives of women's mental health, 27(4), 637–647. https://doi.org/10.1007/s00737-024-01447-z  

Bernstein, E. E., Klare, D., Weingarden, H., Greenberg, J. L., Snorrason, I., Hoeppner, S. S., Vanderkruik, R., Harrison, O., & Wilhelm, S. (2024). Impact of sleep disruption on BDD symptoms and treatment response. Journal of affective disorders, 346, 206–213. https://doi.org/10.1016/j.jad.2023.11.028 

Vanderkruik, R. C., Ferguson, C., Kobylski, L. A., Locascio, J. J., Hamlett, G. E., Killenberg, P. C., Lewis, R., Jones, N., Rossa, E. T., Dineen, H., Picard, R., & Cohen, L. S. (2024). Testing a Behavioral Activation Gaming App for Depression During Pregnancy: Multimethod Pilot Study. JMIR formative research, 8, e44029. https://doi.org/10.2196/44029 

Viguera, A. C., Jones, A., Szpunar, M. J., Bernstein, S. N., Killenberg, P. C., Sojka, E. T., Rossa, E. T., Gaccione, P., Freeman, M. P., & Cohen, L. S. (2024). The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Journal of Women's Health, 0(0), null. https://doi.org/10.1089/jwh.2024.0033

Freeman MP. Extreme dysphoria of pregnancy: a distinct syndrome warranting attention? J Clin Psychiatry. 2024;85(3):23com15238.

Swetlik, C., Cohen, L. S., Kobylski, L. A., Sojka, E. T., Killenberg, P. C., Freeman, M. P., & Viguera, A. C. (2024). Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric Medications. The Journal of Clinical Psychiatry, 85(1).

Vanderkruik, R., Freeman, M. P., Dunn, K., Clifford, C., Dimidjian, S., Cohen, L. S. (2023). The challenge of clinical research and suicidality: Participant feedback on a safety protocol. Journal of Clinical Psychiatry. 84(00):22m14737.

Vanderkruik, R., Freeman, M. P., Nonacs, R., Jellinek, M., Gaw, M. L., Clifford, C. A., Bartels, S., & Cohen, L. S. (2023). To screen or not to screen: Are we asking the right question? In response to considering de-implementation of universal perinatal depression screening. General hospital psychiatry, 83, 81–85.

Cohen, L. S., Vanderkruik, R., Arakelian, M., Church, T. R., Dunk, M. M., & Freeman, M. P. (2023). Establishment of the MGH Postpartum Psychosis Project: MGHP3. PloS one, 18(2), e0281133.

Cohen, L. S., Church, T. R., Freeman, M. P., Gaccione, P., Caplin, P. S., Kobylski, L. A., Arakelian, M., Rossa, E. T., Chitayat, D., Hernández-Díaz, S., & Viguera, A. C. (2023). Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. Journal of women's health (2002), 32(4), 452–462.

Viguera, A. C., McElheny, S. A., Caplin, P. S., Kobylski, L. A., Rossa, E. T., Young, A. V., Gaccione, P., Góez-Mogollón, L., Freeman, M. P., & Cohen, L. S. (2023). Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications. The Journal of clinical psychiatry, 84(1), 22m14492.

Freeman, M. P., Szpunar, M. J., Kobylski, L. A., Harmon, H., Viguera, A. C., & Cohen, L. S. (2022). Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications. Archives of women's mental health, 25(5), 923–928.

Szpunar, M. J., Freeman, M. P., Kobylski, L. A., Caplin, P. S., Gaccione, P., Viguera, A. C., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2022). Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Depression and anxiety, 39(12), 751–759.

Viguera, A. C., Vanderkruik, R., Gaccione, P., Caplin, P. S., Kobylski, L. A., Freeman, M. P., & Cohen, L. S. (2022). Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics. Archives of women's mental health, 25(2), 511–516.

Baker, A. S., Wales, R., Noe, O., Gaccione, P., Freeman, M. P., & Cohen, L. S. (2022). The Course of ADHD during Pregnancy. Journal of attention disorders, 26(2), 143–148.

Viguera, A. C., Freeman, M. P., Góez-Mogollón, L., Sosinsky, A. Z., McElheny, S. A., Church, T. R., Young, A. V., Caplin, P. S., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2021). Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. The Journal of clinical psychiatry, 82(4), 20m13745.

Freeman, M. P., Viguera, A. C., Góez-Mogollón, L., Young, A. V., Caplin, P. S., McElheny, S. A., Church, T. R., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2021). Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Archives of women's mental health, 24(4), 659–667.

Joffe, H., de Wit, A., Coborn, J., Crawford, S., Freeman, M., Wiley, A., Athappilly, G., Kim, S., Sullivan, K. A., Cohen, L. S., & Hall, J. E. (2020). Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms. The Journal of clinical endocrinology and metabolism, 105(3), e642–e650.

Freeman, M. P., Goez-Mogollon, L., Sosinsky, A. Z., Church, T. R., McElheny, S. A., Viguera, A. C., & Cohen, L. S. (2019). The impact of obesity on pregnancy outcomes among women with psychiatric disorders: Results from a prospective pregnancy registry. Journal of psychosomatic research, 123, 109735.

Raffi, E. R., Nonacs, R., & Cohen, L. S. (2019). Safety of Psychotropic Medications During Pregnancy. Clinics in perinatology, 46(2), 215–234.

Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., & Soares, C. N. (2019). Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of women’s health (2002), 28(2), 117–134.

Freeman, M. P., Sosinsky, A. Z., Goez-Mogollon, L., Savella, G. M., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2018). Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. Psychosomatics, 59(2), 125–134.

Freeman, M. P., Claypoole, L. D., Burt, V. K., Sosinsky, A. Z., Moustafa, D., Noe, O. B., Cheng, L. J., & Cohen, L. S. (2018). Course of major depressive disorder after pregnancy and the postpartum period. Depression and anxiety, 35(12), 1130–1136.

Cohen, L. S., Góez-Mogollón, L., Sosinsky, A. Z., Savella, G. M., Viguera, A. C., Chitayat, D., Hernández-Díaz, S., & Freeman, M. P. (2018). Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. The American journal of psychiatry, 175(12), 1225–1231.

Freeman, M. P., Lee, H., Savella, G. M., Sosinsky, A. Z., Marfurt, S. P., Murphy, S. K., & Cohen, L. S. (2018). Predictors of Depressive Relapse in Women Undergoing Infertility Treatment. Journal of women’s health (2002), 27(11), 1408–1414.

Freeman, M. P., Farchione, T., Yao, L., Sahin, L., Taylor, L., Huybrechts, K. F., Nonacs, R., Sosinsky, A. Z., Viguera, A. C., & Cohen, L. S. (2018). Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule. The Journal of clinical psychiatry, 79(4), 18ah38120.

Freeman, M. P., Góez-Mogollón, L., McInerney, K. A., Davies, A. C., Church, T. R., Sosinsky, A. Z., Noe, O. B., Viguera, A. C., & Cohen, L. S. (2018). Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. General hospital psychiatry, 53, 73–79.

Park, Y., Hernandez-Diaz, S., Bateman, B. T., Cohen, J. M., Desai, R. J., Patorno, E., Glynn, R. J., Cohen, L. S., Mogun, H., & Huybrechts, K. F. (2018). Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. The American journal of psychiatry, 175(6), 564–574.

Mitchell, C. M., Srinivasan, S., Plantinga, A., Wu, M. C., Reed, S. D., Guthrie, K. A., LaCroix, A. Z., Fiedler, T., Munch, M., Liu, C., Hoffman, N. G., Blair, I. A., Newton, K., Freeman, E. W., Joffe, H., Cohen, L., & Fredricks, D. N. (2018). Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause (New York, N.Y.), 25(5), 500–507.

Freeman, M. P., Sosinsky, A. Z., Goez-Mogollon, L., Savella, G. M., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2018). Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. Psychosomatics, 59(2), 125–134.

Raffi, E., Freeman, M. P. (2017) The etiology of premenstrual dysphoric disorder: five interwoven pieces. Current Psychiatry, 9, 20-28.

Panchaud, A., Hernandez-Diaz, S., Freeman, M. P., Viguera, A. C., MacDonald, S. C., Sosinsky, A. Z., & Cohen, L. S. (2017). Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. Journal of psychiatric research, 95, 84–90.

Freeman, M. P., Cheng, L. J., Moustafa, D., Davies, A., Sosinsky, A. Z., Wang, B., Petrillo, L. F., Hogan, C., & Cohen, L. S. (2017). Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29(4), 249–257.

Suri, R., Stowe, Z. N., Cohen, L. S., Newport, D. J., Burt, V. K., Aquino-Elias, A. R., Knight, B. T., Mintz, J., & Altshuler, L. L. (2017). Prospective Longitudinal Study of Predictors of Postpartum-Onset Depression in Women With a History of Major Depressive Disorder. The Journal of clinical psychiatry, 78(8), 1110–1116.

Sosinsky, A. Z., Freeman, M. P., Savella, G. M., Cheng, L. J., Viguera, A. C., & Cohen, L. S. (2017). Delusional Pregnancy Presenting to the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Journal of clinical psychopharmacology, 37(4), 472–474.

Patorno, E., Huybrechts, K. F., Bateman, B. T., Cohen, J. M., Desai, R. J., Mogun, H., Cohen, L. S., & Hernandez-Diaz, S. (2017). Lithium Use in Pregnancy and the Risk of Cardiac Malformations. The New England journal of medicine, 376(23), 2245–2254.

Huybrechts, K. F., Hernández-Díaz, S., Patorno, E., Desai, R. J., Mogun, H., Dejene, S. Z., Cohen, J. M., Panchaud, A., Cohen, L., & Bateman, B. T. (2016). Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA psychiatry, 73(9), 938–946.

Freeman M. P. (2016). Wishful thinking is not effective contraception: family planning, contraception, and safe prescribing. The Journal of clinical psychiatry, 77(4), 523–524.

Cohen, L. S., & Nonacs, R. (2016). Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks. JAMA psychiatry, 73(11), 1170–1172.

Joffe, H., Crawford, S. L., Freeman, M. P., White, D. P., Bianchi, M. T., Kim, S., Economou, N., Camuso, J., Hall, J. E., & Cohen, L. S. (2016). Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. The Journal of clinical endocrinology and metabolism, 101(10), 3847–3855.

Freeman, M. P., Sosinsky, A. Z., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2016). Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Archives of women’s mental health, 19(3), 437–441.

Meyer, F., Freeman, M. P., Petrillo, L., Barsky, M., Galvan, T., Kim, S., Cohen, L., & Joffe, H. (2016). Armodafinil for fatigue associated with menopause: an open-label trial. Menopause (New York, N.Y.), 23(2), 209–214.

Hogan, C. S., & Freeman, M. P. (2016). Adverse Effects in the Pharmacologic Management of Bipolar Disorder During Pregnancy. The Psychiatric clinics of North America, 39(3), 465–475.

Cohen, L. S., Viguera, A. C., McInerney, K. A., Freeman, M. P., Sosinsky, A. Z., Moustafa, D., Marfurt, S. P., Kwiatkowski, M. A., Murphy, S. K., Farrell, A. M., Chitayat, D., & Hernández-Díaz, S. (2016). Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. The American journal of psychiatry, 173(3), 263–270.

Cohen, L. S., Viguera, A. C., McInerney, K. A., Kwiatkowski, M. A., Murphy, S. K., Lemon, E. L., & Hernández-Díaz, S. (2015). Establishment of the National Pregnancy Registry for Atypical Antipsychotics. The Journal of clinical psychiatry, 76(7), 986–989.

Freeman, M. P. (2015). Psychotropic medication use during pregnancy: changes to the labeling system and the importance of exposure registries. The Journal of clinical psychiatry, 76(7), 990–991.

Habecker, E., Freeman, M. P. (2015) Awareness and management of obstetrical complications of depression. Current Psychiatry, 14(12):39-44.

Caan, B., LaCroix, A. Z., Joffe, H., Guthrie, K. A., Larson, J. C., Carpenter, J. S., Cohen, L. S., Freeman, E. W., Manson, J. E., Newton, K., Reed, S., Rexrode, K., Shifren, J., Sternfeld, B., & Ensrud, K. (2015). Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (New York, N.Y.), 22(6), 607–615.

Joffe, H., LaCroix, A. Z., & Cohen, L. (2015). Concern about the use of venlafaxine to treat vasomotor symptoms–reply. JAMA internal medicine, 175(4), 658–659.

Freeman, M. P., Cohen, L. S., & McInerney, K. (2014). Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy. Journal of clinical psychopharmacology, 34(5), 627–632.

Psaros, C., Freeman, M., Safren, S. A., Barsky, M., & Cohen, L. S. (2014). Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression. Journal of clinical psychopharmacology, 34(4), 455–460.

Cohen, L. S., Joffe, H., Guthrie, K. A., Ensrud, K. E., Freeman, M., Carpenter, J. S., Learman, L. A., Newton, K. M., Reed, S. D., Manson, J. E., Sternfeld, B., Caan, B., Freeman, E. W., LaCroix, A. Z., Tinker, L. F., Booth-Laforce, C., Larson, J. C., & Anderson, G. L. (2014). Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (New York, N.Y.), 21(4), 347–354.

Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., & Hernández-Díaz, S. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. The New England journal of medicine, 370(25), 2397–2407.

Psaros, C., Freeman, M., Safren, S. A., Barsky, M., & Cohen, L. S. (2014). Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression. Journal of clinical psychopharmacology, 34(4), 455–460.

Freeman M. P. (2014). Perinatal psychiatry: an emerging specialty. The Journal of clinical psychiatry, 75(10), 1086–1087.

Joffe, H., Guthrie, K. A., LaCroix, A. Z., Reed, S. D., Ensrud, K. E., Manson, J. E., Newton, K. M., Freeman, E. W., Anderson, G. L., Larson, J. C., Hunt, J., Shifren, J., Rexrode, K. M., Caan, B., Sternfeld, B., Carpenter, J. S., & Cohen, L. (2014). Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA internal medicine, 174(7), 1058–1066.

Cohen, L. S., Joffe, H., Guthrie, K. A., Ensrud, K. E., Freeman, M., Carpenter, J. S., Learman, L. A., Newton, K. M., Reed, S. D., Manson, J. E., Sternfeld, B., Caan, B., Freeman, E. W., LaCroix, A. Z., Tinker, L. F., Booth-Laforce, C., Larson, J. C., & Anderson, G. L. (2014). Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (New York, N.Y.), 21(4), 347–354.

Freeman M. P. (2014). ADHD and pregnancy. The American journal of psychiatry, 171(7), 723–728.

Freeman, M. P., Toth, T. L., & Cohen, L. S. (2013). Assisted reproduction and risk of depressive relapse: considerations for treatment. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 25(4), 283–288.

Freeman, M. P., Hirschberg, A. M., Wang, B., Petrillo, L. F., Connors, S., Regan, S., Joffe, H., & Cohen, L. S. (2013). Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas, 75(2), 170–174.

Sternfeld, B., LaCroix, A., Caan, B. J., Dunn, A. L., Newton, K. M., Reed, S. D., Guthrie, K. A., Booth-LaForce, C., Sherman, K. J., Cohen, L., Freeman, M. P., Carpenter, J. S., Hunt, J. R., Roberts, M., & Ensrud, K. E. (2013). Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemporary clinical trials, 35(1), 25–34.

Joffe, H., Guthrie, K. A., Larson, J., Cohen, L. S., Carpenter, J. S., Lacroix, A. Z., & Freeman, E. W. (2013). Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network. Menopause (New York, N.Y.), 20(3), 261–268.

Freeman, M. P., Walker, R., Laughren, T. P., Miller, K. K., & Fava, M. (2013). Female reproductive life cycle and hormones: methodology to improve clinical trials. The Journal of clinical psychiatry, 74(10), 1018–1021.

Freeman, M. P., Joffe, H., Cohen, L. S. (2012). Postpartum depression: Help patients find the right treatment. Current Psychiatry, 14-21.

Ensrud, K. E., Joffe, H., Guthrie, K. A., Larson, J. C., Reed, S. D., Newton, K. M., Sternfeld, B., Lacroix, A. Z., Landis, C. A., Woods, N. F., & Freeman, E. W. (2012). Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause (New York, N.Y.), 19(8), 848–855.

Gibson, C. J., Joffe, H., Bromberger, J. T., Thurston, R. C., Lewis, T. T., Khalil, N., & Matthews, K. A. (2012). Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstetrics and gynecology, 119(5), 935–941.

Joffe, H., Chang, Y., Dhaliwal, S., Hess, R., Thurston, R., Gold, E., Matthews, K. A., & Bromberger, J. T. (2012). Lifetime history of depression and anxiety disorders as a predictor of quality of life in midlife women in the absence of current illness episodes. Archives of general psychiatry, 69(5), 484–492.

Rogines-Velo, M. P., Heberle, A. E., & Joffe, H. (2012). Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy. Menopause (New York, N.Y.), 19(4), 471–475.

Freeman, M. P., Hibbeln, J. R., Silver, M., Hirschberg, A. M., Wang, B., Yule, A. M., Petrillo, L. F., Pascuillo, E., Economou, N. I., Joffe, H., & Cohen, L. S. (2011). Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause (New York, N.Y.), 18(3), 279–284.

Freeman, E. W., Guthrie, K. A., Caan, B., Sternfeld, B., Cohen, L. S., Joffe, H., Carpenter, J. S., Anderson, G. L., Larson, J. C., Ensrud, K. E., Reed, S. D., Newton, K. M., Sherman, S., Sammel, M. D., & LaCroix, A. Z. (2011). Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA, 305(3), 267–274.

Joffe, H., Petrillo, L. F., Koukopoulos, A., Viguera, A. C., Hirschberg, A., Nonacs, R., Somley, B., Pasciullo, E., White, D. P., Hall, J. E., & Cohen, L. S. (2011). Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. The Journal of clinical endocrinology and metabolism, 96(7), E1044–E1054.

Cohen, L. S., Wang, B., Nonacs, R., Viguera, A. C., Lemon, E. L., & Freeman, M. P. (2010). Treatment of mood disorders during pregnancy and postpartum. The Psychiatric clinics of North America, 33(2), 273–293.

Freeman, M. P., Mischoulon, D., Tedeschini, E., Goodness, T., Cohen, L. S., Fava, M., & Papakostas, G. I. (2010). Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. The Journal of clinical psychiatry, 71(6), 682–688.

Joffe, H., Petrillo, L., Viguera, A., Koukopoulos, A., Silver-Heilman, K., Farrell, A., Yu, G., Silver, M., & Cohen, L. S. (2010). Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. American journal of obstetrics and gynecology, 202(2), 171.e1–171.e11.

Viguera, A. C., Cohen, L. S., Whitfield, T., Reminick, A. M., Bromfield, E., & Baldessarini, R. J. (2010). Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists. Archives of women’s mental health, 13(2), 175–178.

Park, E. R., Chang, Y., Quinn, V., Regan, S., Cohen, L., Viguera, A., Psaros, C., Ross, K., & Rigotti, N. (2009). The association of depressive, anxiety, and stress symptoms and postpartum relapse to smoking: a longitudinal study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 11(6), 707–714.

Viguera, A. C., Emmerich, A. D., & Cohen, L. S. (2008). Case records of the Massachusetts General Hospital. Case 24-2008. A 35-year-old woman with postpartum confusion, agitation, and delusions. The New England journal of medicine, 359(5), 509–515.

Pearson, K. H., Nonacs, R. M., Viguera, A. C., Heller, V. L., Petrillo, L. F., Brandes, M., Hennen, J., & Cohen, L. S. (2007). Birth outcomes following prenatal exposure to antidepressants. The Journal of clinical psychiatry, 68(8), 1284–1289.

Joffe, H., Soares, C. N., Petrillo, L. F., Viguera, A. C., Somley, B. L., Koch, J. K., & Cohen, L. S. (2007). Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. The Journal of clinical psychiatry, 68(6), 943–950.

Cohen L. S. (2007). Treatment of bipolar disorder during pregnancy. The Journal of clinical psychiatry, 68 Suppl 9, 4–9.

Viguera, A. C., Whitfield, T., Baldessarini, R. J., Newport, D. J., Stowe, Z., Reminick, A., Zurick, A., & Cohen, L. S. (2007). Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. The American journal of psychiatry, 164(12), 1817–1923.

Viguera, A. C., Newport, D. J., Ritchie, J., Stowe, Z., Whitfield, T., Mogielnicki, J., Baldessarini, R. J., Zurick, A., & Cohen, L. S. (2007). Lithium in breast milk and nursing infants: clinical implications. The American journal of psychiatry, 164(2), 342–345.

Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of general psychiatry, 63(4), 385–390.

Cohen, L. S., Nonacs, R. M., Bailey, J. W., Viguera, A. C., Reminick, A. M., Altshuler, L. L., Stowe, Z. N., & Faraone, S. V. (2004). Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Archives of women’s mental health, 7(4), 217–221.

Cohen, L. S., Altshuler, L. L., Stowe, Z. N., & Faraone, S. V. (2004). Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study. Psychotherapy and psychosomatics, 73(4), 255–258.

Cohen, L. S., Nonacs, R., Viguera, A. C., & Reminick, A. (2004). Diagnosis and treatment of depression during pregnancy. CNS spectrums, 9(3), 209–216.

Cohen L. S. (2003). Gender-specific considerations in the treatment of mood disorders in women across the life cycle. The Journal of clinical psychiatry, 64 Suppl 15, 18–29.

Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004). Management of bipolar disorder during pregnancy and the postpartum period. The American journal of psychiatry, 161(4), 608–620.

Joffe, H., Cohen, L. S., & Harlow, B. L. (2003). Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. American journal of obstetrics and gynecology, 189(6), 1523–1530.

Joffe, H., Soares, C. N., & Cohen, L. S. (2003). Assessment and treatment of hot flushes and menopausal mood disturbance. The Psychiatric clinics of North America, 26(3), 563–580.

Viguera, A. C., Cohen, L. S., Baldessarini, R. J., & Nonacs, R. (2002). Managing bipolar disorder during pregnancy: weighing the risks and benefits. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 47(5), 426–436.

Viguera, A. C., Cohen, L. S., Bouffard, S., Whitfield, T. H., & Baldessarini, R. J. (2002). Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. The American journal of psychiatry, 159(12), 2102–2104.

Freeman E. W. (2002). Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 7 Suppl 3, 27–43.

Cohen, L. S., Viguera, A. C., Bouffard, S. M., Nonacs, R. M., Morabito, C., Collins, M. H., & Ablon, J. S. (2001). Venlafaxine in the treatment of postpartum depression. The Journal of clinical psychiatry, 62(8), 592–596.

Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000). Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. The American journal of psychiatry, 157(2), 179–184.

Cohen, L. S., Sichel, D. A., Robertson, L. M., Heckscher, E., & Rosenbaum, J. F. (1995). Postpartum prophylaxis for women with bipolar disorder. The American journal of psychiatry, 152(11), 1641–1645.

Cohen, L. S., Friedman, J. M., Jefferson, J. W., Johnson, E. M., & Weiner, M. L. (1994). A reevaluation of risk of in utero exposure to lithium. JAMA, 271(2), 146–150.

Share: